From January 13th to 16th, 2020, Co-founders of Bridge Point Capital, Nadia Tian and Mark Young participated in the 2020 J.P. Morgan Healthcare Conference in San Francisco. They also took part in the Conference’s peripheral events such as WuXi Global Forum 2020, BFC Global Healthcare Investment Conference, and Asia America MultiTechnology Association (AAMA) Global Healthcare Conference.
As the most influential annual grand gathering in the healthcare space, the J.P. Morgan Healthcare Conference this year has brought 9000+ healthcare specialists and 450+ enterprises to discuss the latest industrial trends and explore synergies and investment opportunities. Since its inception event 38 years ago, it has been a tradition that hundreds of formal or unofficial forums, conferences and corporate receptions concurrently take place in San Francisco amid the J.P. Morgan Healthcare Conference Week. For every practitioner within the healthcare field, these events are a golden chance to expedite business development opportunities, source strategic partners, and extend industrial networks. For those who are in the space of U.S. - China cross-border investments, events hosted by WuXi AppTec, BFC, and AAMA are favored the most due to their deep connections with the vast China market.
In addition to receiving updates on cutting-edge technologies and leading industrial trends, the Co-founders of Bridge Point Capital also attended several peripheral events to expand our current network and seek cooperation opportunities within the U.S.-China investment space. “This San Francisco trip was a great inspiration to our team,” said by Mark Young, “Almost everyone we talked to these days expressed interests in our business model and potential partnerships with us in terms of cross-border transactions”. “Bridge Point Capital focuses on raising capital for our portfolio companies, but also attaches tremendous importance on creating value-add after investing.” Said Nadia Tian, “Having live conversations with Chinese partners is critical to our future success, and we always keep in mind that keeping U.S.-China investment channels open is the foundation of our business.”
Bridge Point Capital is a private equity firm based in New York with a focus on U.S.-China cross-border investment. We invest in disruptive late-stage healthcare companies that can benefit from penetrating the vast, yet unexplored, Chinese healthcare market. We aim to leverage our expertise in both healthcare and capital markets to provide the best investment platform we possibly can for our investors.